An Evaluation Of The Chinese Pharmaceutical Market
Loading...
Authors
Zhang, Mei
Issue Date
1991
Type
Thesis
Language
en_US
Keywords
Alternative Title
Abstract
Some of the major products produced in China include antibiotics, cancer medications, vitamins and cardiovascular drugs. However, due to the lack of domestic manufacturing or availability, several pharmaceuticals need to be imported. Furthermore, the
Chinese market needs different types of product formulations. For
example, doctors prefer an oral formulation as opposed to
injectible. Both doctors and patients would benefit from the
conveniences of an oral formulation. Additionally, pediatricians
seek medications made specifically for children as opposed to the
adult strength. In order to help develop health-care in China, the
state has been required to promote the use of both western style
and Traditional Chinese Medicine {TCM) since 1983. Foreign industries who invest into China's pharmaceutical
market should study the country's goals, prospects, and priorities
as part of their feasibility studies prior to investing. Joint
ventures that meet the needs of China will have excellent
prospects. In the long term, as joint venture enhance China's
technology the PRC will further allow foreign companies to invest
in and profit from needed development projects. Although, foreign
joint ventures must recognize the impossibility of foreign
ownership and control. As with other joint ventures, conducting
business can pose various risks, but these risks can be overcome.
Description
xii, 92 p.
Citation
Publisher
License
U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder.